American Cancer Society recommends routine prostate cancer screening for men 50 to 69
Միայն փաստեր

American Cancer Society recommends routine prostate cancer screening for men 50 to 69

Ամփոփում

The American Cancer Society updated its prostate cancer screening guidelines, advising biennial PSA tests for average-risk men aged 50-69 and annual testing for higher-risk groups.

The American Cancer Society has revised its prostate cancer screening recommendations, now advising routine PSA blood tests for men aged 50 to 69 who are at average risk. For men at higher risk – including Black men and those with a family history of prostate cancer – the Society suggests annual screening starting at age 45.

The new guidance follows recent research indicating that regular screening can lower mortality from prostate cancer while newer diagnostic tools, such as MRI and additional blood tests, help reduce unnecessary biopsies and treatments.

"The bottom line is it has been shown to reduce the risk of dying from prostate cancer," said Andrew Wolf, a University of Virginia cancer prevention expert and member of the Society's Guideline Development Committee.

Wolf noted that overtreatment has been a concern because many prostate cancers grow slowly and may never cause harm. Potential side effects of unnecessary procedures include sexual dysfunction and urinary incontinence.

The updated guidelines also advise against routine screening for men 75 and older unless they have previously recorded elevated PSA levels. The recommendation aligns with the U.S. Preventive Services Task Force, which continues to encourage shared decision-making between patients and physicians.

Աղբյուր

NPR

Շարունակեք կարդալ — անվճար

Ստեղծեք անվճար հաշիվ՝ նորություններին հետևելու համար։ Քարտ չի պահանջվում։